计算方法用于模拟抗性结节细胞分裂超级家族的多药物排泄
Mohd Athar1, Silvia Gervasoni1, Giuliano Malloci1
1Physics Department, University of Cagliari, Monserrato, Italy.
Methods in enzymology
|November 27, 2025
概括
计算方法提供了对多药物排泄 (抵抗结节-细胞分裂超级家族) 的关键见解,有助于抗生素耐药性研究. 这些工具有助于了解转运器动态和抑制格兰氏阴性细菌的策略.
科学领域:
- 生物化学和分子生物学
- 计算生物学 计算生物学
- 微生物学 微生物学
背景情况:
- 多种药物排泄,特别是抵抗结节细胞分裂 (RND) 超级家族,对于细菌抗生素耐药性至关重要.
- 阴性细菌利用这些来获得内在和获得的耐药性,这给临床带来了重大挑战.
研究的目的:
- 为RND流量系统应用的计算方法提供详细的协议.
- 为这些方法提供关于软件,输入准备和分析的实际指导.
- 讨论计算方法在流量研究中的优点,局限性和应用.
主要方法:
- 同性学建模的模拟.
- 分子对接是分子对接.
- 所有原子分子动力学模拟的模拟.
- 有约束力的自由能源估计.
主要成果:
- 本章详细介绍了用于RND排水的常用计算技术的实际实施.
- 提供了指导方针,以避免陷,并确保计算研究的可复制性.
- 在模型的实用性和局限性与实验验证进行了比较.
结论:
- 计算方法对于理解RND排泄机制,基板相互作用和抑制剂设计是非常宝贵的.
- 这些方法可以系统地研究传送器动态和多特异性.
- 提出的方法可以适应研究其他临床相关的膜载体.
相关概念视频
Carrier-Mediated Transport
981
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
981
The Significance of Membrane Transport
40.9K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
40.9K
Cellular Membranes and Drug Transport
1.4K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.4K
ABC Transporters: Exporter
6.2K
ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.2K
Pore Transport and Ion-Pair Transport
1.1K
Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
1.1K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


